Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer’s disease: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2022.2027905
Abstract: ABSTRACT Background Donepezil is a first-line drug for the treatment of Alzheimer’s disease (AD). However, there are no meta-analyses on efficacy and safety of high-dose versus standard-dose donepezil in the treatment of moderate-to-severe AD. Research… read more here.
Keywords: standard dose; analysis; dose donepezil; high dose ... See more keywords